Zoetis Quarterly Income Statement
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis revenue and earnings
In the quarter ended Jun 30, 2026, Zoetis generated $2.47 billion in revenue, down 0.2% from the same quarter a year earlier. Net income was $691.0 million (-4.8% year over year), for a net margin of 28.0% versus a median of 27.4% in the prior 5 quarters. Gross margin was 72.7% (down from 73.2%).
Diluted earnings per share came in at $1.65, up from $1.63.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.47B | 2.26B | 2.39B | 2.40B | 2.47B | 2.20B | 2.32B | 2.39B | 2.36B | 2.19B | 2.21B | 2.15B |
| Revenue growth (YoY) | -0.24% | +2.91% | +3.02% | +0.50% | +4.79% | +0.37% | +4.70% | +11.02% | +8.30% | +9.50% | +8.48% | +7.44% |
| Cost of Revenue | 673.00M | 641.00M | 712.00M | 683.00M | 664.00M | 618.00M | 707.00M | 701.00M | 668.00M | 643.00M | 728.00M | 638.00M |
| Gross Profit | 1.79B | 1.62B | 1.68B | 1.72B | 1.81B | 1.58B | 1.61B | 1.69B | 1.69B | 1.55B | 1.49B | 1.51B |
| Research & Development | 173.00M | 180.00M | 199.00M | 170.00M | 166.00M | 162.00M | 186.00M | 167.00M | 171.00M | 162.00M | 174.00M | 152.00M |
| Selling, General & Admin | 592.00M | 588.00M | 619.00M | 579.00M | 614.00M | 574.00M | 625.00M | 565.00M | 581.00M | 547.00M | 565.00M | 525.00M |
| Interest Expense | 61.00M | 62.00M | 57.00M | 58.00M | 53.00M | 54.00M | 51.00M | 57.00M | 59.00M | 58.00M | 59.00M | 59.00M |
| Other Income (Expense) | 5.00M | 20.00M | 9.00M | 13.00M | -2.00M | 15.00M | 20.00M | 16.00M | -25.00M | 8.00M | 8.00M | -6.00M |
| Pretax Income | 866.00M | 758.00M | 761.00M | 887.00M | 912.00M | 773.00M | 732.00M | 874.00M | 780.00M | 747.00M | 650.00M | 717.00M |
| Income Tax | 175.00M | 157.00M | 158.00M | 166.00M | 186.00M | 171.00M | 151.00M | 182.00M | 156.00M | 148.00M | 127.00M | 121.00M |
| Net Income | 691.00M | 601.00M | 603.00M | 721.00M | 726.00M | 602.00M | 581.00M | 682.00M | 624.00M | 599.00M | 525.00M | 596.00M |
| Net Income growth (YoY) | -4.82% | -0.17% | +3.79% | +5.72% | +16.35% | +0.50% | +10.67% | +14.43% | -7.00% | +8.51% | +13.88% | +12.67% |
| EPS (Basic) | 1.65 | 1.42 | 1.43 | 1.63 | 1.63 | 1.34 | 1.28 | 1.51 | 1.37 | 1.31 | 1.15 | 1.29 |
| EPS (Diluted) | 1.65 | 1.42 | 1.42 | 1.63 | 1.63 | 1.34 | 1.29 | 1.50 | 1.37 | 1.31 | 1.14 | 1.29 |
| Shares Outstanding (Basic) | 417.60M | 422.10M | — | 442.90M | 445.10M | 447.60M | — | 452.90M | 455.50M | 458.00M | — | 460.30M |
| Shares Outstanding (Diluted) | 417.70M | 422.40M | — | 443.20M | 445.50M | 448.00M | — | 453.50M | 456.00M | 458.80M | — | 461.40M |
| Gross Margin | 72.73% | 71.66% | 70.17% | 71.54% | 73.16% | 71.88% | 69.49% | 70.64% | 71.71% | 70.64% | 67.10% | 70.34% |
| Net Margin | 28.00% | 26.57% | 25.26% | 30.04% | 29.35% | 27.39% | 25.08% | 28.56% | 26.43% | 27.35% | 23.72% | 27.71% |
This table shows 12 quarterly periods of Zoetis's income statement, from Q2 2026 back to Q3 2023, across 16 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a income statement?